Takeda's oncology discovery strategy

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Takeda's Oncology Discovery Strategy is tightly integrated and focused on first and fast-bestin-class products and product combinations. Core areas of expertise include hormones,protein homeostasis, biotherapeutics and signal transduction. Strategic imperatives for research success are understanding of unmet needs, focus on biological expertise in foundational areas of leadership and flexibility to adapt to new information. © The Author 2013. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

DeSchuytner, B., Kuvalanka, K., Hibner, B., & Bolen, J. (2013, April). Takeda’s oncology discovery strategy. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyt023

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free